1. Home
  2. NEWP vs EMBC Comparison

NEWP vs EMBC Comparison

Compare NEWP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Pacific Metals Corp.

NEWP

New Pacific Metals Corp.

N/A

Current Price

$4.10

Market Cap

575.1M

Sector

N/A

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$10.74

Market Cap

602.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEWP
EMBC
Founded
1972
1924
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
575.1M
602.3M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
NEWP
EMBC
Price
$4.10
$10.74
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$4.25
$18.50
AVG Volume (30 Days)
1.1M
920.8K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
5.59%
EPS Growth
N/A
20.90
EPS
N/A
0.74
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$14.50
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$9.20
52 Week High
$4.70
$15.55

Technical Indicators

Market Signals
Indicator
NEWP
EMBC
Relative Strength Index (RSI) 62.94 47.02
Support Level $3.31 $9.54
Resistance Level $4.70 $10.87
Average True Range (ATR) 0.30 0.66
MACD 0.06 0.09
Stochastic Oscillator 100.00 22.91

Price Performance

Historical Comparison
NEWP
EMBC

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: